Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Karuna Therapeutics, Inc.

Karuna Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
From Karuna Therapeutics, Inc.
Via Business Wire
Tickers KRTX
Karuna Therapeutics Appoints Bill Meury as President and Chief Executive Officer
From Karuna Therapeutics, Inc.
Via Business Wire
Tickers KRTX
Karuna Therapeutics Reports Third Quarter 2022 Financial Results and Provides General Business Updates
From Karuna Therapeutics, Inc.
Via Business Wire
Tickers KRTX
Karuna Therapeutics to Present at the Jefferies 2022 London Healthcare Conference
From Karuna Therapeutics, Inc.
Via Business Wire
Tickers KRTX
Karuna Therapeutics to Present Data from the Phase 3 EMERGENT-2 Trial of KarXT in Schizophrenia at the 35th European College of Neuropsychopharmacology (ECNP) Congress
From Karuna Therapeutics, Inc.
Via Business Wire
Tickers KRTX
Karuna Therapeutics to Present at Upcoming Investor Conferences
From Karuna Therapeutics, Inc.
Via Business Wire
Tickers KRTX
Karuna Therapeutics Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares
From Karuna Therapeutics, Inc.
Via Business Wire
Tickers KRTX
Karuna Therapeutics Announces Pricing of Public Offering of Common Stock
From Karuna Therapeutics, Inc.
Via Business Wire
Tickers KRTX
Karuna Therapeutics Announces Proposed Public Offering of Common Stock
From Karuna Therapeutics, Inc.
Via Business Wire
Tickers KRTX
Karuna Therapeutics Reports Second Quarter 2022 Financial Results and Provides General Business Updates
From Karuna Therapeutics, Inc.
Via Business Wire
Tickers KRTX
Karuna Therapeutics Announces Positive Results from Phase 3 EMERGENT-2 Trial of KarXT in Schizophrenia
From Karuna Therapeutics, Inc.
Via Business Wire
Tickers KRTX
Karuna Therapeutics to Present at Upcoming Investor Conferences
From Karuna Therapeutics, Inc.
Via Business Wire
Tickers KRTX
Karuna Therapeutics to Host Virtual Event Highlighting Clinical Program for Psychosis in Alzheimer’s Disease
From Karuna Therapeutics, Inc.
Via Business Wire
Tickers KRTX
Karuna Therapeutics Reports First Quarter 2022 Financial Results and Provides General Business Update
From Karuna Therapeutics, Inc.
Via Business Wire
Tickers KRTX
Karuna Therapeutics to Present at the 2022 RBC Capital Markets Global Healthcare Conference
From Karuna Therapeutics, Inc.
Via Business Wire
Tickers KRTX
Karuna Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides General Business Update
From Karuna Therapeutics, Inc.
Via Business Wire
Tickers KRTX
Karuna Therapeutics to Present at the SVB Leerink 11th Annual Global Healthcare Conference
From Karuna Therapeutics, Inc.
Via Business Wire
Tickers KRTX
Karuna Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
From Karuna Therapeutics, Inc.
Via Business Wire
Tickers KRTX
Karuna Therapeutics Appoints Charmaine Lykins as Chief Commercial Officer
From Karuna Therapeutics, Inc.
Via Business Wire
Tickers KRTX
Karuna Therapeutics and Zai Lab Announce Strategic Collaboration for Development, Manufacturing, and Commercialization of KarXT in Greater China
From Karuna Therapeutics, Inc.
Via Business Wire
Tickers KRTX
Karuna Therapeutics to Present at Upcoming Investor Conferences
From Karuna Therapeutics, Inc.
Via Business Wire
Tickers KRTX
Karuna Therapeutics Reports Third Quarter 2021 Financial Results and Provides General Business Update
From Karuna Therapeutics, Inc.
Via Business Wire
Tickers KRTX
Karuna Therapeutics to Present at 2021 Virtual Wells Fargo Healthcare Conference
From Karuna Therapeutics, Inc.
Via Business Wire
Tickers KRTX
Karuna Therapeutics to Present at the Citi 16th Annual BioPharma Virtual Conference
From Karuna Therapeutics, Inc.
Via Business Wire
Tickers KRTX
Karuna Therapeutics Reports Second Quarter 2021 Financial Results and Provides General Business Update
From Karuna Therapeutics, Inc.
Via Business Wire
Tickers KRTX
Karuna Therapeutics to Present at 2021 Wedbush PacGrow Healthcare Virtual Conference
From Karuna Therapeutics, Inc.
Via Business Wire
Tickers KRTX
Karuna Therapeutics Announces Results from Phase 1b Trial Evaluating the Safety and Tolerability of KarXT in Healthy Elderly Volunteers
From Karuna Therapeutics, Inc.
Via Business Wire
Tickers KRTX
Karuna Therapeutics to Present at Upcoming Investor Conferences
From Karuna Therapeutics, Inc.
Via Business Wire
Tickers KRTX
Karuna Therapeutics Reports First Quarter 2021 Financial Results and Provides General Business Update
From Karuna Therapeutics, Inc.
Via Business Wire
Tickers KRTX
Karuna Therapeutics to Present at Upcoming Investor Conferences
From Karuna Therapeutics, Inc.
Via Business Wire
Tickers KRTX
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.